Molecular genetics of familial amyloidotic polyneuropathy

Journal of the Peripheral Nervous System

Volumn 1, Issue 3, 1996, Pages 179-188

  Saraiva, Maria João Mascarenhas ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Amyloid; Cardiomyopathy; Familial amyloidotic polyneuropathy; Peripheral nerve; Transthyretin

Indexed keywords

PREALBUMIN;

AMYLOID NEUROPATHY; GENETICS; HUMAN; MUTATION; PATHOLOGY; PERIPHERAL NEUROPATHY; PORTUGAL; PREVALENCE; REVIEW;

AMYLOID NEUROPATHIES; HUMANS; MUTATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PORTUGAL; PREALBUMIN; PREVALENCE;

EID: 0030307672     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Andrade C: A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75:408-427.
2. Saraiva MJM, Birken S, Costa PP, Goodman DS: Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of a molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 1984;74:104-119.
3. Dwulet FE, Benson MD: Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc. Natl. Acad. Sci. USA 1984; 81:694-698.
4. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S: Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem. Biophys. Res. Commun. 1983; 116:880-889.
5. Suzuki T, Azuma T, Araki S, Ikegawa S, Kito S, Matsubayashi H, Yanagisawa N, Ikeda S: Treatment of autonomic dysfunction with L-threo-3,4-dihydroxyphenyl-serine in patients with familial amyloidotic polyneuropathy. In: Amyloid and Amyloidosis. (Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds). New York: Plenum Press, 1988 pp 851-856.
6. Guimarães A, Pinheiro AV, Leite I: Sural nerve biopsy in familial amyloidotic polyneuropathy. In: Amyloid and Amyloidosis. (Isobe T, Araki S, Uchino F, Kito S, Tsubura E, eds). New York: Plenum Press, 1988 pp 493-498.
7. Blake CCF, Geisow MJ, Oatley SJ, Rérat B, Rérat C: Structure of prealbumin: secondary, tertiary and quaternary interaction determined by Fourier refinement at 1.8 Ångstrom. J. Mol. Biol. 1978; 121: 339-356.
8. Saraiva MJM, Costa PP, Goodman DS: Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine 30 variant. J. Clin. Invest. 1985; 76:2171-2177.
9. Altland K, Banzhoff A: Separation by hybrid isoelectric focusing of normal human plasma transthyretin (prealbumin) and a variant with a methionine for valine substitution associated with familial amyloidotic polyneuropathy. Electrophoresis 1986; 7:529-533.
10. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y: Structure of the chromosomal gene for human serum prealbumin. Gene 1985; 37:191-197.
11. Sasaki H, Sakaki Y, Matsuo H, Goto I, Kuroiwa Y, Sahashi I, Takahashi A, Shinoda T, Isobe T, Takagi Y: Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques. Biochem. Biophys. Res. Commun. 1984; 125:636-642.
12. Saraiva MJM, Costa PP, Goodman DS: Genetic expression of a transthyretin mutation in typical and late onset cases in Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986; 36:1413-1417.
13. Almeida MR, Alves IL, Sakaki Y, Costa PP, Saraiva MJM: Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30. Human Genetics 1990; 85:623-626.
14. Sousa A, Coelho T, Barros J, Sequeiros J: Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-Type I in Póvoa do Varzim and Vila do Conde (North of Portugal). Am. J. Med. Genetics 1995; 60:512-521.
15. Alves IL, Altland K, Almeida MR, Winter P, Saraiva MJM: Screening and biochemical characterization of transthyretin variants in the Portuguese population. Human Mutation. In press.
16. Andersson R: Hereditary amyloidosis with polyneuropathy. Acta Med. Scand. 1970; 188:85-94.
17. Holmgren G, Costa PMP, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, Teixeira A, Saraiva MJM, Costa PP: Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J. of Med. Genetics 1994;31:351-354.
18. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O: Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Human Heredity 1993;43:288-294.
19. Coelho T, Sousa A, Lourenço E, Ramalheira J: A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. [Review]. J. of Med. Genetics 1994;31:293-299.
20. Coelho T, Chorão R, Sousa A, Alves IL, Torres MF, Saraiva MJM: Compound heterozygotes of transthyretin Met 30 and transthyretin Met 119 are protected from the devastating effects of familial amyloid polyneuropathy. Neuromuscular Disorders (Suppl) 1996; 6:S20.
21. Alves IL, Jacobson DR, Torres MF, Coelho T, Holmgren G, Saraiva MJM: Compound heterozygosity in patients with TTR-related amyloidosis. Neuromuscular Disorders (Suppl) 1996; 6:S19.
22. Holmgren G, Haettner E, Norderson I, Sandgren O, Steen L, Lundgren E: Homozygosity for the trans-thyretin-Met30-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin Genetics 1988; 34:333-338.
23. Araki S: Type I familial amyloidotic polyneuropathy (Japanese type). Brain Develop. 1984; 6:128-133.
24. Munar-Qués M, Costa PP, Saraiva MJM: The Majorcan focus of familial amyloidotic polyneuropathy type I. In: Familial amyloidotic polyneuropathy and other trans-thyretin related disorders. (Costa PP, Freitas AF, Saraiva MJM, eds.). Arq. Med. Porto 1990; 3: 13-18.
25. Salvi F, Ferlini A, Plasmati R, Rubboli G, Michelucci R, Forti A, Saraiva MJM, Costa PP, Altland K, Tassinari: Familial Amyloidotic Polyneuropathy in Italy. In: Familial amyloidotic polyneuropathy and other transthyretin related disorders. (Costa PP, Falcão de Freitas A, Saraiva MJM, eds.). Arq. Med. Porto 1990; 3:19-24.
26. Saraiva MJM, Sherman W, Goodman DS: Presence of a plasma transthyretin (prealbumin) variant in familial amyloidotic polyneuropathy in a kindred of Greek origin. J. Lab. Clin. Med. 1986; 108:17-22.
27. Holt IJ, Harding AE, Middleton L, Crysostomou G, Said G, King RHM, Thomas PK: Molecular genetics of amyloid neuropathy in Europe. Lancet I 1989; 524-526.
28. Grateau G, Adams D, Malapert D, Viemont M, Delpech M, et al: Late-onset familial amyloid polyneuropathy with the TTR Met 30 mutation in France. Clin. Genetics 1993; 43:143-145.
29. Linke RP, Altland K, Palha JA, Almeida MR, Saraiva MJM: Transthyretin point mutations in familial amyloid polyneuropathy from Germany using RFLP on PCR-amplified DNA from paraffin sections. In: Amyloid and Amyloidosis (Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, eds), New York: Parthenon Publishing, 1994 pp 444-446.
30. André S, Novis SAP, Cruz MW: Familial amyloidotic polyneuropathy of the Portuguese type (Type I) in Rio de Janeiro, Brazil: origin and geographic distribution of 22 families. In: Familial amyloidotic polyneuropathy and other transthyretin related disorders. (Costa PP, Falcão de Freitas A, Saraiva MJM, eds.). Arq. Med. Porto 1990; 3:9-12.
31. Léger JM, Grateau G, Gugenheim M, Hauw JJ, Bouche P, Brunet P: Genetic expression of a transthyretin mutation in a case of amyloidotic polyneuropathy occurring in an African. Neurology 1994; 44:181.
32. Yoshioka K, Furuya H, Sasaki H, Saraiva MJM, Costa PP, Sakaki Y: Haplotype analysis of familial amyloidotic polyneuropathy: evidence for multiple origins of the Val-Met mutation most common to the disease. Human Genetics 1989; 82:9-13.
33. Almeida MR, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Qués M, Benson MD, Skinner M, Costa PP, Saraiva MJM: Haplotype analysis of common transthyretin mutations. Human Genetics 1995; 96:350-354.
34. Uemichi T, Murrell JR, Zeldenrust S, Benson MD: A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J. Med. Genet. 1992; 29:888-891.
35. Booth DR, Booth SE, Persey MR, Tan SY, Madhoo S, Pepys MB, Hawkins PN: Three new amyloidogenic TTR mutations: Pro 12, Glu 18, Val 33. Neuromuscular Disorders (Suppl) 1996; 6:S20.
36. Jones LA, Skare JC, Cohen AS, Harding JA, Milunsky A, Skinner M: Familial amyloidotic polyneuropathy: a new transthyretin position-30 mutation (alanine for valine) in a family of German descent. Clin. Genet. 1992; 41:70-73.
37. 30 Leu) associated with familial amyloidotic polyneuropathy. FEBS Letters 1992; 306:206-208.
38. Nakazato M, Kangawa K, Minamino N, Tawara S, Matsuo H, Araki S: Revised analysis of amino acid replacement in a prealbumin variant (SKO-III) associated with familial amyloidotic polyneuropathy of Jewish origin. Biochem. Biophys. Res. Commun. 1984; 123:921-928.
39. Li S, Minnerath S, Li K, Dyck PJ, Sommer SS: Two tiered DNA based diagnosis of transthyretin amyloidosis reveals two novel point mutations. Neurology 1991; 41:893-898.
40. Reilly MM, Adams D, Booth DR, Davis MB, Said G, et al.: Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-856.
41. Jones LA, Skare JC, Harding JA, Cohen AS, Milunsky A, Skinner M: Proline at position 36: A new transthyretin mutation associated with familial amyloidotic polyneuropathy. Am. J. Hum. Genet. 1991; 48:979-982.
42. Ueno S, Uemichi T, Takahashi N, Soga F, Yorifuji S, Tarui S: Two novel variants of TTR identified in Japanese cases with familial amyloidotic polyneuropathy. Biochem. Biophys. Res. Commun. 1990; 169:1117-1121.
43. Murakami T, Maeda S, Yi S, Ikegawa S, Kawashima E, Onodera S, Shimada K, Araki S: A novel transthyretin mutation associated with familial amyloidotic polyneuropathy. Biochem. Biophys. Res. Commun. 1992; 182:520-526.
44. Saeki Y, Ueno S, Takahashi, N, Soga F, Yanagihara T: A novel mutant (Transthyretin Ile 50) related to amyloid polyneuropathy- single-strand conformation polymorphism as a new genetic marker. FEBS Letters 1992; 308:35-37.
45. Booth DR, Soutar AK, Hawkins PN, Pepys MB. Three new amyloidogenic transthyretin gene mutations: advantages of direct sequencing. In: Amyloid and amyloidosis. (Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, eds). New York: Parthenon Publishing, 1993 pp 456-458.
46. 55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Human Genetics 1992; 89: 353-356.
47. 61→Lys) causes familial amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced mutation restriction analysis. Biochem. Biophys. Res. Commun. 1993; 194:1090-1096.
48. Almeida MR, Lopez-Andreu F, Munarqués M, Costa PP, Saraiva MJ: Transthyretin Ala 71: a new transthyretin variant in a Spanish family with familial amyloidotic polyneuropathy. Hum. Mutation 1993; 2:420-421.
49. Wallace MR, Dwulet FE, Williams EC, Conneally PM, Benson MD: Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J. Clin. Invest. 1988; 81:189-193.
50. Ueno S, Uemichi T, Yorifuji S, Tarui S: A novel variant of transthyretin (Tyr 114 to Cys) deduced from the nucleotide sequences of the gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem. Biophys. Res. Commun. 1990; 169:143-147.
51. Uemichi T, Liepnieks JJ, Waits RP, Benson MD: In frame deletion in the transthyretin gene ( V122) associated with amyloidotic polyneuropathy. Neuromuscular Disorders (Suppl) 1996; 6:S21.
52. Patrosso MC, Vezzoni P, Salvi F, Gobbi P, Winter P, Altland K, Ferlini A: Two new mutations in the transthyretin gene, leading to polyneuropathy and cardio-myopathy in two unrelated Italian families. Neuromuscular Disorders (Suppl) 1996; 6:S23.
53. Ferlini A, Patrosso MC, Repetto M, Frattini A, Villa A, Fini S, Salvi F, Vezzoni P, Forabosco A: A new mutation (TTR Ala-47) in the trans-thyretin gene associated with hereditary amyloidosis TTR-related. Hum. Mutation 1994; 4:61-64.
54. Almeida MR, Ferlini A, Forabosco A, Gawinowicz MA, Costa PP, Salvi F, Plasmati R, Tassinari A, Altland K, Saraiva MJ: Two transthyretin variants (TTR Ala-49 and TTR-Gln 89) in two Sicilian kindreds with hereditary amyloidosis. Human Mutation 1992; 1:211-215.
55. Benson MD II, Turpin JC, Lucotte G, Zeldenrust S, LeChevalier B, Benson MD: A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family. J. of Med. Genetics 1993;30:120-122.
56. Wallace MR, Dwulet FE, Conneally PM, Benson MD: Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J. Clin. Invest. 1986;78:6-12.
57. Yasuda T, Sobue G, Doyu M, Nakazato M, Shiomi K, Yanagi T, Mitsuma T: Familial amyloidotic polyneuropathy with late-onset and well preserved autonomic function - a Japanese kindred with novel mutant transthyretin (Ala 97 to Gly). J Neurol. Sci. 1994; 121:97-102.
58. 112 Ile) causes an amyloid neuropathy with severe cardiac impairment. Clin. Neuropathol. 1993; 12:S44.
59. Dwulet FE, Benson MD: Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/ Swiss). J Clin. Invest. 1986; 78:880-886.
60. Nichols WC, Liepnieks JJ, McKusick VA, Benson MD: Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics 1989; 5:535-540.
61. Saeki Y, Ueno S, Yorifuji S, Sugiyama Y, Ide Y, Matsuzawa Y: New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis. Biochem. Biophys. Res. Commun. 1991; 180:380-385.
62. Izumoto S, Marione RL, Younger D, Hays AP, Smith RT, Herbert J: Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation: asparagine 70. Neurology 1992; 42:2094-2102.
63. Skinner M, Harding J, Skare I, Jones LA, Cohen AS, Milunsky A, Skare J: A new transthyretin mutation associated with amyloidotic vitreous opacities - Asparagine for isoleucine at position 84. Ophtalmol. 1992; 99:503-508.
64. Jacobson D, Gertz MA, Buxbaum JN: Transthyretin VAL 107, a new variant associated with familial cardiac and neuropathic amyloidosis. Human Mutation 1994; 3:399-401.
65. Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, Ando M: Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 1994; 44:315-318.
66. Reilly MM, Staunton H, Harding AE: Familial amyloid polyneuropathy (TTR Ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. J. of Neurol. Neuros & Psych. 1995; 59:45-49.
67. Torres MF, Almeida MR, Saraiva MJ: TTR exon scanning in peripheral neuropathies. Neuromuscular Disorders 1995;5:187-191.
68. Zeldenrust S, Skinner M, Skare J, Benson MD: A new transthyretin variant (His 69) associated with vitreous amyloid in an FAP family. Amyloid: Int J Exp Clin Invest 1994; 1:17-22.
69. Herbert J, Younger D, Latov N, Martone RL: Clinical spectrum of familial amyloidotic polyneuropathy. In: Amyloid and amyloidosis. (Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, eds). New York: Parthenon Publishing, 1994 pp 486-488.
70. Vidal R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, Frangione B, Wisniewski T: Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G). Am. J. Pathol. 1996; 148:361-366.
71. Jenne DE, Denzel K, Blatzinger P, Winter P, Obermaier B, Linke RP, Altland K: A new isoleucine substitution Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc. Natl. Acad. Sci. USA 1996; 93:6302-6307.
72. Araki S, Ikegawa S: Transthyretin and apo A I amyloidosis. In: Amyloid and amyloidosis (Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, eds). New York: Parthenon Publishing, 1993; pp 422-427.
73. Saraiva MJM, Almeida MR, Sherman W, Gawinowicz MA, Costa PM, Costa PP, Goodman DS: A new trans-thyretin mutation associated with amyloid cardiomyopathy. Am. J. Hum. Genet. 1992; 50:1027-1030.
74. Jacobson D, Gertz MA, Kane I, Buxbaum JN: Genetic analysis of 9 unrelated patients with transthyretin (TTR)-cardiac amyloidosis: correlation of clinical and genetic findings and description of 2 new TTR variants. In: Amyloid and amyloidosis (Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle T, Young I, eds). New York: Parthenon Publishing, 1994; pp 474-476.
75. Nishi H, Kimura A, Harada H, Hayashi Y, Nakamura M, Sasazuki T: Novel variant transthyretin gene (Ser 50 to Ile) in familial cardiac amyloidosis. Biochem. Biophys. Res. Commun. 1992; 187:460-466.
76. Thr→Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995; 91:962-967.
77. Almeida MR, Hesse A, Steinmetz A, Maisch B, Altland K, Linke RP, Gawinowicz MA, Saraiva MJ: Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res. Cardiology 1991; 86:567-571.
78. Nordlie M, Sletten K, Husby G, Ranlov PJ: A new prealbumin variant in familial amyloidotic cardiomyopathy of Danish origin. Scand. J. Immunol. 1988; 27:119-122.
79. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B: Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J. Clin. Invest. 1989; 83:836-843.
80. Saraiva MJM, Sherman W, Marboe C, Figueira A, Costa PP, Freitas AF, Gawinowicz MA: Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant. Scand J. Immunol. 1990; 32:341-346.
81. Ferlini A, Rapezzi C, Magnani B, Winter P, Altland K, Vezzoni P, Patrosso MC: A compound heterozygous patient for two TTR mutations affected with restrictive amyloidotic cardiomyopathy. Neuromuscular Disorders (Suppl) 1996; 6:S23.
82. Jacobson DR, Reveille JD, Buxbaum JN: Frequency and genetic background of the position 122 (Val-Ile) variant transthyretin gene in the black population. Am. J. Hum. Genet. 1991; 49:192-198.
83. Westermark P, Sletten K, Johansson B, Cornwell GG III: Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA 1990; 87:2843-2845.
84. Jacobson DR, Alves IL, Saraiva MJ, Thibodeau SN, Buxbaum JN: Transthyretin Ser 6 gene frequency in individuals without amyloidosis. Human Genetics 1995; 95:308-312.
85. Uemichi T, Liepnieks JJ, Altland K, Benson MD: Identification of a novel non-amyloidogenic transthyretin polymorphism (His 74) in the German population. Amyloid: Int. J. Exp. Clin. Invest. 1994; 1:149-153.
86. Saraiva MJM, Almeida MR, Alves IL, Moreira P, Gawinowicz MA, Costa PP, Rauh S, Banzhoff A, Altland K: Molecular analyses of an acidic transthyretin Asn 90 variant. Am. J. of Hum. Genet. 1991;48:1004-1008.
87. Almeida MR, Altland K, Rauh S, Gawinowicz MA, Moreira P, Costa PP, Saraiva MJ: Characterization of a basic transthyretin variant TTR-Arg 102 in the German population. Biochem. Biophys. Acta 1991; 1097:224-226.
88. Moses AC, Rosen HN, Moller DE, Tsuzuki S, Haddow JE, Lawlor J, Liepnieks JJ, Nichols WC, Benson MD: A Point Mutation in Transthyretin Increases Affinity for Thyroxine Binding and Produces Euthyroid Hyperthyroxinemia. J. Clin. Invest. 1990; 86: 2025-2033.
89. Izumoto S, Kornberg J, Herbert J: Two transthyretin mutations associated with euthyroid hyperthyroxinemia. J. Rheumatol. 1993; 20:186.
90. Van Allen M, Frohlich J, Davis J: Inherited predisposition to generalized amyloidosis. Neurology 1969; 19:10-25.
91. Nichols WC, Gregg RE, Brewer J, Benson MD: A mutation in apolipoprotein AI in the Iowa-type of familial amyloid polyneuropathy. Genomics 1990; 8:318-323.
92. Meretoja J: Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previous unrecognized heritable syndrome. Ann. Clin. Res. 1969; 1:314-324.
93. Maury CPJ: Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J. Clin. Invest. 1991; 87:1195-1199.
94. Saraiva MJM: Transthyretin mutations in health and disease. Human Mutation 1995; 5:191-196.
95. Shimada K, Maeda S, Murakami T, Nishiguchi S, Tashiro F, Yi S, Wakasugi S, Takahashi K, Yamamura K: Transgenic mouse model of familial amyloidotic polyneuropathy. Mol. Biol. Med. 1989; 6:333-343.
96. Nagata Y, Tashiro F, Yi S, Murakami T, Maeda S, Takahashi K, Shimada K, Okamura H, Yamamura K: A 6-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse. J. Biochem. 1995; 117:169-175.
97. 30). Clin. Genetics 1991; 40:242-246.
98. Holmgren G, Ericzon B-G, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB: Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341:1113-1116.
99. Matsunami H, Makuuchi M, Kawasaki S, Hashikura Y, Ikegami T, Nakazawa Y, Miyagawa S, Takei Y, Ikeda S, Yanagisawa N: A case of familial amyloid polyneuropathy treated with partial liver transplantation using a graft from a living related donor. Transplantation 1995; 60:301-303.
100. Ericzon B-G: Liver transplantation for familial amyloid polyneuropathy - report from the world registry. Neuromuscular Disorders (Suppl) 1996;6:S65.
101. Lewis WD, Skinner M: Liver transplantation for familial amyloidotic polyneuropathy: a potentially curative treatment. Amyloid: Int. J. Exp. Clin. Invest. 1994; 1:143-144.
102. Ando Y, Tanaka Y, Nakazato M, Ericzon BG, Yamashita T, Tashima KK, Sakashita N, Suga M, Uchino M, Ando M: Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem. Biophys. Res. Commun. 1995; 211:354-358.